DNA MEX Week ended 24 Jul 2026

Weekly Investor Report

Name: DNA weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

Ginkgo Bioworks Holdings, Inc. · Healthcare · Biotechnology

Open interactive chart View report data

Latest close 170.0 MXN

0.0% latest week

Weekly setup

Mixed setup

The weekly trend is not active. Price is -3.8% below the Trend Line and sits at 14.4% of its 52-week range. The latest completed week returned 0.0%, after a 13.3% four-week move. The latest news-sentiment score is 47/100.

Setup score 31 out of 100

Latest Close 170.0 MXN 24 Jul 2026

1W Return 0.0% latest completed week

4W Return 13.3% short-term follow-through

12W Return -3.5% quarterly tape

Trend Breadth 21.2% 11 of 52 weeks active

Volume Ratio - vs 13-week average

What is working

Activity pressure is positive on the latest completed week.

What could go wrong

The trend backdrop is inactive, so price action has not confirmed a constructive regime.
Price is below the Trend Line, which keeps downside pressure in focus.
Price is below Fair Value, so the market is still discounting the latest tape.
Next-week expectancy is negative at 5.56% based on similar historical setup states.

What to watch next

Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.

Price follow-through 0.0% Latest completed week; four-week move 13.3%. Indicator stack 12/87 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 5.56% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 47/100 22 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -3.8% below the Trend Line and sits at 14.4% of its 52-week range. The latest completed week returned 0.0%, after a 13.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

150.0 MXN 14.4% 289.0 MXN

Range location14.4%Shows where the latest close sits between the 52-week low and high.

Trend distance-3.8%Price premium or discount versus the weekly Trend Line.

Fair-value gap-66.3%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-41.2%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is - the 13-week average. Participation data is incomplete.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1112-week average 0.05

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.11Current proprietary activity-pressure read.

Buy signals1Accumulation signal count in the latest 12 weeks.

Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 13.3% over four weeks, -3.5% over 12 weeks, and -28.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.0%

4W13.3%

12W-3.5%

26W-3.5%

52W-28.3%

Active trend streak0 weeks

Active weeks in one year11

Trend breadth21.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure0.86Latest activity-pressure read.

Pressure change274.2%Four-week change in activity pressure.

Leadership-22.99Latest relative-leadership reading.

RS change34.9%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment47/100

Weighted news tone is neutral across 22 relevant articles.

2 positive · 17 neutral · 3 negative

Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-41.2%Distance below the 52-week high.

13-week volatility5.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

30 Jan 27 Feb 27 Mar 24 Apr 22 May 19 Jun 24 Jul

Weeks higher1 of 261 weeks finished lower.

Best week+13.3%Week of 3 Jul.

Worst week-14.8%Week of 15 May.

Latest week+0.0%Week of 24 Jul.

Shape of recent returns

Strong gains1

Modest gains0

Flat weeks24

Modest losses0

Sharp losses1

Recent vol5.5%13-week weekly-return volatility.

Base vol6.8%52-week weekly-return volatility.

Up/down split2/2Count of positive and negative weeks in the 52-week window.

Average skew17.6% / -26.9%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorMX Healthcare

4-week rank4 / 78

Group average0.9%

Trend breadth26.9%

Trend26.9%active weekly trend signals

MD61.5%positive activity pressure

RS32.1%positive relative leadership

Four-week leaders

INCY · MEX21.5%TDOC · MEX15.8%VEEV · MEX15.5%DNA · MEX13.3%TMO · MEX13.0%

IndustryMX Biotechnology

4-week rank2 / 19

Group average-2.7%

Trend breadth21.1%

Trend21.1%active weekly trend signals

MD52.6%positive activity pressure

RS21.1%positive relative leadership

Four-week leaders

INCY · MEX21.5%DNA · MEX13.3%KYNB · MEX7.9%ALT1 · MEX2.9%REGN · MEX0.0%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape25/100

Trend, activity pressure, participation, and risk combine to a 25/100 tape read.

Indicator analysis21/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.

Activity pressure 0.11; No reversal markers Next-Week ExpectancyNegative 5.56%

Next-week expectancy is negative with a 5.56% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment47/100

Weighted news tone is neutral across 22 relevant articles.

Ginkgo Bioworks (NYSE: DNA) awards RSUs to 10% owner Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
24 Jul 2026	170.0 MXN	0.0%	176.7 MXN	505.0 MXN	0.86	-22.99	0	Off
17 Jul 2026	170.0 MXN	0.0%	180.7 MXN	514.0 MXN	0.50	-23.98	0	Off
10 Jul 2026	170.0 MXN	0.0%	184.7 MXN	523.4 MXN	0.14	-24.54	0	Off
3 Jul 2026	170.0 MXN	13.3%	188.6 MXN	529.7 MXN	-0.18	-25.86	20	Off
26 Jun 2026	150.0 MXN	0.0%	192.6 MXN	536.0 MXN	-0.49	-35.31	0	Off
19 Jun 2026	150.0 MXN	0.0%	197.2 MXN	542.5 MXN	-0.43	-36.03	0	Off
12 Jun 2026	150.0 MXN	0.0%	201.9 MXN	548.9 MXN	-0.40	-37.12	0	Off
5 Jun 2026	150.0 MXN	0.0%	206.5 MXN	555.4 MXN	-0.31	-36.22	0	Off
29 May 2026	150.0 MXN	0.0%	211.1 MXN	561.9 MXN	-0.09	-39.23	54	Off
22 May 2026	150.0 MXN	0.0%	215.8 MXN	568.3 MXN	0.08	-39.76	0	Off
15 May 2026	150.0 MXN	-14.8%	220.4 MXN	574.3 MXN	0.27	-40.16	53	Off
8 May 2026	176.1 MXN	0.0%	225.0 MXN	579.0 MXN	0.25	-32.44	0	Off
1 May 2026	176.1 MXN	0.0%	228.8 MXN	583.5 MXN	0.04	-31.20	0	Off
24 Apr 2026	176.1 MXN	0.0%	230.8 MXN	588.1 MXN	-0.22	-33.28	0	Off

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.